AVTX vs MS · P/E 0.0, rev $441.0K vs P/E 20, $344.27B cap
Avalo Therapeutics Inc (AVTX) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
MS does not have a complete income-statement cache yet.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the AVTX and MS stock pages for the full models.
Not investment advice.